9 research outputs found

    Distribution of ARV treatment lines given to patients (up to 31/12/2012).

    No full text
    <p>AZT: zidovudine; 3TC: lamivudine; EFV: efavirenz;</p><p>NEV: nevirapine; FTC: emtricitabine;</p><p>TDF: tenofovir disoproxil fumarate; LPV: lopinavir;</p><p>RTV: ritonavir; D4T: stavudine.</p><p>Distribution of ARV treatment lines given to patients (up to 31/12/2012).</p

    Boxplot representing the ENA indices.

    No full text
    <p>The Total System Throughput (TST), the Average path Length (APL), the relative Ascendency (A/DC), the Average Mutual Information (AMI), the internal relative Ascendency (A<sub>i</sub>/C<sub>i</sub>) ,the Finn Cycling Index (FCI). These indices were calculated with the 500 000 solutions of the MCMC- LIM implementation. Red crosses correspond to outliers. Medians of all these indices were significantly different for the two seasons (Wilcoxon test, H<sub>0</sub> was rejected, p-value < 0.01).</p
    corecore